Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Ihde

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Annals of Internal Medicine|September 1, 1985
Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-upB E Johnson, D C Ihde, P A Bunn, et al.
Investigational New Drugs|January 1, 1985
Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusionG Batist, R W Klecker, H N Jayaram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, I R Linnoila, et al.
Journal of the National Cancer Institute|August 2, 1989
MDR1 gene expression in lung cancerS L Lai, L J Goldstein, M M Gottesman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostateE J Seifter, P A Bunn, M H Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trialD L Longo, V T DeVita, P L Duffey, et al.
Medicine|January 1, 1982
Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experienceS T Rosen, J Aisner, R W Makuch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapyD L Longo, E Glatstein, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, D L Breneman, et al.
The American Journal of Medicine|December 1, 1983
Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapyM Brower, D C Ihde, A Johnston-Early, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Annals of Internal Medicine|September 1, 1985
Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-upB E Johnson, D C Ihde, P A Bunn, et al.
Investigational New Drugs|January 1, 1985
Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusionG Batist, R W Klecker, H N Jayaram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, I R Linnoila, et al.
Journal of the National Cancer Institute|August 2, 1989
MDR1 gene expression in lung cancerS L Lai, L J Goldstein, M M Gottesman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostateE J Seifter, P A Bunn, M H Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trialD L Longo, V T DeVita, P L Duffey, et al.
Medicine|January 1, 1982
Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experienceS T Rosen, J Aisner, R W Makuch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapyD L Longo, E Glatstein, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndromeF M Foss, D C Ihde, D L Breneman, et al.
The American Journal of Medicine|December 1, 1983
Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapyM Brower, D C Ihde, A Johnston-Early, et al.
Pageof 13